$SENS Stock grants to the management is pretty common in any organization and its good for share holders because the more stocks they own, the more responsibility they have to increase their stock value. Also 180 day sensor will be in the market early next year for commercial sales in US and trails will continue for 365 day sensor.. The combination of product, technology, patents, 180 & 360 day sensor approvals, EU & US footprint will be an easy sell. Read a report about Eversense technology and how accurate it is when compared to other competing products, its features and how important it is for diabetes patients; a cool technology which can grow and supplement other requirements in future. Its been long since we heard any news from the management, something big like buyout or partnership process must be brewing for sure.